The Importance of Early Recognition of KSHV-Mediated Syndromes: A Case Report - 28/09/21
, Divya Kondapi, MD b, Andrew R. DiNardo, MD b, c, d, Ramya Ramaswami, MD, MPH e, Elizabeth Chiao, MD f, g, Eva H. Clark, MD, PhD b, hThomas J. Marrie, MD, Section Editor
El texto completo de este artículo está disponible en PDF.Esquema
| Funding: Development of this manuscript was supported in part by facilities and services at the Houston VA HSR&D Center for Innovations in Quality, Effectiveness and Safety (CIN13-413) Advanced Fellowships Program in Health Services Research (EHC). |
|
| Conflicts of Interest: ARDN reports support from NIAID K23 AI141681-02, DoD W81XWH1910026, Thrasher Research Fund, and Cellgene/BMS. RR reports receiving research support from Celgene/BMS, Merck, EMD-Serano, Jassen, and CTI Biopharma through a CRADA at the NCI. NJS-L, DK, EC, report none. |
|
| Authorship: All authors had access to the data and a role in writing this manuscript. |
Vol 134 - N° 10
P. e503-e506 - octobre 2021 Regresar al númeroBienvenido a EM-consulte, la referencia de los profesionales de la salud.
El acceso al texto completo de este artículo requiere una suscripción.
¿Ya suscrito a @@106933@@ revista ?
